Maravai LifeSciences Holdings, Price Today
Maravai LifeSciences Holdings,
MRVI
Healthcare
$1.98B
💰
Market Cap
0
💸
Price to Earnings
$-0.9
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
6 |
Strong Buy |
8 |
Hold |
4 |
Sell |
0 |
Strong Sell |
0 |
MRVI Price Forecast Target
7.9 👉 14.0 +78%
MRVI EPS Forecast
-0.9 👉 0.1 +-106%
Financials
Profit Margin
-41 %
Revenue Growth
-63.8 %
Dividend
$ 0
Held Percent
2.4% - Insiders
102.6% - Institutions
-5.0% - Public
Major Fund Holders
-
💰 GTCR, LLC $170.6M
-
💰 12 West Capital Management Lp $91.3M
-
💰 Vanguard Group Inc $78.7M
-
💰 Blackrock Inc. $51.0M
-
💰 Massachusetts Financial Services Co. $47.3M
Stock Ideas
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…
Steven Cohen Portfolio
Steven Cohen, the legendary trader and billionaire founder of Stamford-based SAC Capital, has established himself as a force to be reckoned with in the hedge fund industry. With a staggering net worth of $8 billion and an impressive $14 billion in …
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…
Christopher Hohn Portfolio
Christopher Hohn is a British hedge fund manager and philanthropist. He founded The Children's Investment Fund Management in 2003, one of Europe's largest hedge funds. Known for his activist investment approach, Hohn targets undervalued companies wi…📮FAQ
Some Frequently Asked Questions.
The Maravai LifeSciences Holdings, industry is Biotechnology
The Maravai LifeSciences Holdings, sector is Healthcare
The Maravai LifeSciences Holdings, forecasted predicted Price to Earnings PE ratio is 157.4
The Maravai LifeSciences Holdings, Price to Earnings PE ratio is 0
The Market Capitalization of Maravai LifeSciences Holdings, is $1.98B
There are total of 98467302 float shares with 102.6% held by Institutions and 2.4% held by insiders
The MMaravai LifeSciences Holdings, forecasted Earnings per Share EPS is $0.1
The Maravai LifeSciences Holdings, Earnings per Share EPS is -0.9
The Maravai LifeSciences Holdings, company has $0 gross profits with -41 profit margins
The Maravai LifeSciences Holdings, Earnings Growth is 0% with 0% quarterly earnings growth
The Maravai LifeSciences Holdings, Revenue is $288944992 with -0.638 revenue growth
The price target for Maravai LifeSciences Holdings, stock is $14.0 for the high target and $6.5 for the low target
The consensus analyst recommendations for Maravai LifeSciences Holdings, is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Maravai LifeSciences Holdings, is Buy, with the following breakdown:
- Buy: 6
- Strong Buy: 8
- Hold: 4
- Sell: 0
- Strong Sell: 0
The Beta of Maravai LifeSciences Holdings, is -0.0
The dividend of Maravai LifeSciences Holdings, is $0
The dividend yield of Maravai LifeSciences Holdings, is 0%
The biggest institutional and mutual fund holders of Maravai LifeSciences Holdings, stock are
- GTCR, LLC
- 12 West Capital Management Lp
- Vanguard Group Inc
- Blackrock Inc.
The Maravai LifeSciences Holdings, ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0